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92Abstract
Evidence suggests that decreased α‐tocopherol (the most biologically active substance in the vita-
min E group) level can cause neurological symptoms, most likely ataxia. The aim of the current
study was to first provide reference intervals for serum tocopherols in the adult Hungarian pop-
ulation with appropriate sample size, recruiting healthy control subjects and neurological patients
suffering from conditions without symptoms of ataxia, myopathy or cognitive deficiency. A vali-
dated HPLC method applying a diode array detector and rac‐tocol as internal standard was uti-
lized for that purpose. Furthermore, serum cholesterol levels were determined as well for data
normalization. The calculated 2.5–97.5% reference intervals for α‐, β/γ‐ and δ‐tocopherols were
24.62–54.67, 0.81–3.69 and 0.29–1.07 μM, respectively, whereas the tocopherol/cholesterol
ratios were 5.11–11.27, 0.14–0.72 and 0.06–0.22 μmol/mmol, respectively. The establishment
of these reference intervals may improve the diagnostic accuracy of tocopherol measurements
in certain neurological conditions with decreased tocopherol levels. Moreover, the current study
draws special attention to the possible pitfalls in the complex process of the determination of ref-
erence intervals as well, including the selection of study population, the application of internal
standard and method validation and the calculation of tocopherol/cholesterol ratios.
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1091 | INTRODUCTION
Most of the deleterious effects of pathological processes in the
human organism are mediated by the formation of reactive species
(RS; Szalárdy, Zádori, Klivényi, Toldi, & Vécsei, 2015). The synthesis
and toxic effects of RS are ameliorated by a complex system of anti-
oxidant machinery, including enzymatic (e.g. superoxide dismutase,
catalase and glutathione peroxidase; Sies, 1997) and nonenzymatic
mechanisms (Figure 1).
The latter group consists of numerous chemical compounds, such
as vitamin E, vitamin C, coenzyme Q10, β‐carotene, glutathione and
flavonoids with proved antioxidant properties (Sies, 1993). In addition
to the capability of these agents to react with RS, their sufficient tissue
concentrations and their suitability for regeneration are desirable prop-
erties as well for efficient antioxidant protection (Rose & Bode, 1993).rt protein; ACN, acetonitrile;
r neurological disease; RI,
hydofurane
wileyonlinelibrary.com/jou
110
111
112The vitamin E group includes four tocotrienols and four tocopherols as
lipid soluble antioxidants. Their molecular structure comprises a
chromanol ringwith an aliphatic side chain, unsaturated for tocotrienols
and saturated for tocopherols. Depending on the number and position
of methyl groups on the chromanol ring, α‐, β‐, γ‐ and δ‐tocotrienols
and tocopherols can be distinguished (Hacquebard & Carpentier,
2005). The bioavailability of tocotrienols is inefficient and physiological
serum concentrations are low (O'Byrne et al., 2000), suggesting that
under normal circumstances their role as antioxidants is negligible.
However, increasing α‐tocotrienol concentration by its external supple-
mentation can ameliorate the symptoms caused by α‐tocopherol defi-
ciency (Sen, Khanna, & Roy, 2007). α‐Tocopherol has the highest
concentration and biological activity from the vitamin E group, while
the other tocopherols have a less expressed role in antioxidant protec-
tion (Hacquebard & Carpentier, 2005). Tocopherols are taken up by the
enterocytes from the intestines and they are incorporated into the
secreted chylomicrons and transported to the liver (Cooper, 1997). In
the liver, the cytosolic α‐tocopherol transport protein (α‐TTP)Copyright © 2017 John Wiley & Sons, Ltd.rnal/bmc 1 of 8
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FIGURE 1 The schematic depiction of
nonenzymatic mechanisms in antioxidant
protection. NADPH, Reduced nicotinamide
adenine dinucleotide phosphate; RS, reactive
species
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114recognizes and binds α‐tocopherol with good selectivity, and themajor-
ity of the other forms of tocopherols are rapidly excreted in the bile. α‐
TTP is responsible for the secretion of α‐tocopherol into plasma and
very‐low‐density lipoprotein particles (Arita, Nomura, Arai, & Inoue,
1997). Very‐low‐density lipoprotein is catabolized on the periphery
by lipoprotein lipase, localized at the endothelium, and the formed
high‐density lipoprotein and low‐density lipoprotein particles become
responsible for the distribution of α‐tocopherol to extrahepatic tissues
(Mardones &Rigotti, 2004).With regard to the other forms of vitamin E,
there is no discrimination between them and α‐tocopherol during
absorption from the intestines; however, in the liver there is a preferen-
tial secretion of α‐tocopherol into the blood, as well as a preferential
metabolism of the other forms (Traber, 2013). Accordingly, cholesterol
levels and metabolism may considerably influence the bioavailability
of tocopherols (Schmölz, Birringer, Lorkowski, & Wallert, 2016).
The major causes of severe tocopherol deficiency are malabsorp-
tion disorders with decreased intestinal lipid uptake (e.g. cholestasis,
cystic fibrosis, short bowel syndrome), abetalipoproteinemia and ataxia
with vitamin E deficiency where the underlying pathological alteration
is the decreased activity of α‐TTP caused by mutations in the TTPA
gene (Morley et al., 2004).
Decreased vitamin‐E levels are associated with several neurolog-
ical symptoms, such as cerebellar ataxia, peripheral neuropathy and
myopathy (Muller, 2010; Ueda et al., 2009), as the nervous system
is particularly sensitive to oxidative damage resulting from reduced
antioxidant capacity (Zádori, Klivényi, Plangár, Toldi, & Vécsei,
2011; Zádori et al., 2012). Accordingly, in addition to the above‐
mentioned disorders with their characteristic symptoms, some other
neuropsychiatric conditions, such as Alzheimer's disease (Lopes da
Silva et al., 2014) and the exacerbation of multiple sclerosis (Karg
et al., 1999) can also be accompanied by significantly reduced serum
or plasma tocopherol levels. Therefore, the measurement of serum
tocopherol levels is advised to be part of the differential diagnostic
process in certain neuropsychiatric conditions. The establishment of
unbiased reference values for the targeted population is essential
for that purpose.
The aim of the current study was to develop an unbiased
method for tocopherol (α‐, β/γ‐ and δ‐tocopherol) measurements
in human serum samples and to hereby establish reference intervals
(RI) via the participation of 120 individuals for the adult Hungarian
population based on the pooling of the values of control subjects
without any chronic disease and neurological patients suffering
from conditions without symptoms of ataxia, myopathy or cognitive
deficiency (the so‐called control group of other neurological
diseases; OND).2 | MATERIALS AND METHODS
2.1 | Materials
The investigated reference compounds {α‐, γ‐, δ‐tocopherol; (2R)‐
2,5,7,8‐tetramethyl‐2‐[(4R,8R)‐(4,8,12‐trimethyltridecyl)]‐6‐chromanol,
(2R)‐2,7,8‐trimethyl‐2‐[(4R,8R)‐4,8,12‐trimethyltridecyl]‐6‐chromanol,
(2R)‐2,8‐dimethyl‐2‐[(4R,8R)‐4,8,12‐trimethyltridecyl]‐6‐chroma-
nol, respectively}, ammonium acetate, ascorbic acid {(5R)‐[(1S)‐1,2‐
dihydroxyethyl]‐3,4‐dihydroxyfuran‐2(5H)‐one}, butylated hydroxy
toluene (BHT), dioxane and methanol were purchased from Sigma‐
Aldrich (Saint Louis, MO, USA), rac‐tocol [2‐methyl‐2‐(4,8,12‐
trimethyltridecyl)‐6‐chromanol, as internal standard] was purchased
from Matreya LLC. (Pleasant Gap, PA, USA), and acetonitrile (ACN),
absolute ethanol, n‐hexane and tetrahydofurane (THF) were purchased
from VWR International (Radnar, PA, USA).2.2 | Enrollment criteria and sample preparation
The study sample population comprised 30 male (age range 21–
71 years, mean age 49.50 year) and 30 female volunteer individuals
(age range 25–76 years, mean age 50.03 year) without any major
chronic illness and 30 male (age range 18–73 years, mean age
49.43 year) and 30 female (age range 24–78 years, mean age
49.60 year) patients with OND (main diagnoses for males were the fol-
lowing: ischemic stroke, 8; Parkinson's disease, 5; epilepsy, 5; lumbar
disk disorder, 3; and other, 9; main diagnoses for females were the fol-
lowing: multiple sclerosis in remission, 8; ischemic stroke, 6; epilepsy,
5; and other, 11) where the presence of ataxia, myopathy or cognitive
dysfunction were excluding criteria. The distribution of the age of the
subjects was Gaussian in all groups (p > 0.05, Anderson–Darling test)
and the variances were equal (p = 0.98, Levene test). There was no sig-
nificant difference between the groups (F = 0.01, p = 0.99, one‐way
ANOVA). The recent regular intake of antihyperlipidemic agents or
any kind of drugs or food supplements containing antioxidants were
exclusion criteria as well in all groups. All participating individuals were
of Hungarian origin and were enrolled in the Department of Neurology
at the University of Szeged. The study was approved by the Ethics
Committee of the Faculty of Medicine, University of Szeged (19/
2007). All study participants gave their written informed consent, in
accordance with the Declaration of Helsinki.
Blood was collected by venipuncture into gold‐top vacutainers fol-
lowing fasting for 12 h. The blood was immediately centrifuged at
3500 rpm for 10min. A 200 μL aliquot of the supernatant serum was
shot into a solution containing 200 μL ascorbic acid (0.085M) and
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71400 μL BHT (1.14mM) and the resulting solution was stored at −80°C
until measurement, while the remaining serum was aliquoted and
stored at −80°C as well.
Before high‐performance liquid chromatography (HPLC) measure-
ment, 600 μL n‐hexane containing 1.14mM BHT and rac‐tocol as inter-
nal standard was added to the freshly thawed serum samples treated
with antioxidants (800 μL). This mixture was mixed for 1min, then cen-
trifuged at 3500 rpm for 5min at 4°C. The hexane layer was trans-
ferred to a test vial and evaporated under nitrogene flow. The
residue was reconstituted with 75 μL ACN and 50 μL EtOH–dioxane
(1:1). The resulting solution was transferred into a 200 μL glass insert
placed into an amber‐colored vial for measurement.
F2 72
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792.3 | Serum cholesterol and triglyceride
measurement
Total cholesterol and triglyceride levels were determined by commer-
cially available kits from Diasys (Diagnostics Systems GmbH, Holzheim,
Germany) on Roche Modular P800 analyser (Roche, Rotkreuz,
Switzerland).80
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1062.4 | Chromatographic conditions
The concentrations of α‐, β/γ‐, δ‐tocopherol were quantified with an
Agilent 1200 HPLC system (Agilent Technologies, Santa Clara, CA,
USA) equipped with an UV/VIS diode array detector applying the mod-
ified method of Hess, Keller, Oberlin, Bonfanti, and Schuep (1991).
Chromatographic separations were performed on an Alltech Prevail
C18 column, 150 × 4.6mm i.d., 5 μm particle size (Alltech Associates
Inc., Deerfield, IL, USA) after passage through a SecurityGuard pre‐
column, 4 × 3.0mm i.d., 5 μm particle size (Phenomenex Inc., Torrance,
CA, USA) with a mobile phase composition of ACN–THF–MeOH–1%
w/v ammonium acetate–distilled water (684:220:68:28:28) applying
isocratic elution. The flow rate and the injection volume were
2.1mL/min and 50 μL, respectively. The detector was set at 292
(α‐tocopherol) and 297 (β/γ‐, δ‐tocopherol, rac‐tocol) nm.
Separating β‐ and γ‐tocopherol is challenging because they only
differ in the position of a methyl group. With the use of a C18 column
these two compounds have almost the same retention times (Saha,
Walia, Kundu, & Pathak, 2013). The β‐ and γ‐tocopherols can only be
separated with the application of special columns and methods
(Gornas et al., 2014; Grebenstein & Frank, 2012), the application of
which may be challenging for routine clinical practice. Accordingly,
only γ‐tocopherol was applied as a standard compound for the estab-
lishment of the calibration curve in this study, and the concentration
at the corresponding retention time includes both substances and is
reported as β/γ‐tocopherol.FIGURE 2 The representative chromatograms of tocopherol
measurement. The gray line represents a blank serum sample which
was spiked with a mixture containing rac‐tocol (1), α‐tocopherol (2), γ‐
tocopherol (4) and δ‐tocopherol (3) (black line). The peak spiked with γ‐
tocopherol may contain β‐tocopherol from the blank serum as well
107
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1142.5 | HPLC method validation for serum samples
2.5.1 | Calibration curve and linearity
Calibrants were prepared in six different concentration levels and
spiked serum samples were used with concentration ranges of 0–40,
0–6, 0–6 and 0–24 μM for α‐, β/γ‐, δ‐tocopherol and rac‐tocol, respec-
tively. The peak area responses were plotted against thecorresponding concentration, and linear regression computations were
carried out by the least square method with the freely available R soft-
ware (R Development Core Team, 2002). Very good linearity
(R2 ≥ 0.99) was observed throughout the concentration ranges for α‐,
β/γ‐, δ‐tocopherol and rac‐tocol.2.5.2 | Selectivity
The selectivity of the method was checked by comparing the chro-
matograms of α‐, β/γ‐, δ‐tocopherol and rac‐tocol for a blank serum
sample and those for a spiked sample. All compounds could be
detected in their own selected chromatograms without any significant
interference, as can be seen in Figure 2.2.5.3 | Precision
For the determination of within‐run precision five samples for four
concentration levels were applied (i.e., 20 replicates altogether). This
study was repeated two more times with at least one week intervals
to obtain between‐run precision. With regard to within‐run precision
the coefficients of variation of the measured concentrations were
4.53, 3.72 and 5.11% for α‐, β/γ‐ and δ‐tocopherols, respectively,
whereas in case of between‐run precision, they were 3.59, 5.93 and
4.76% for α‐, β/γ‐ and δ‐tocopherol, respectively.2.5.4 | Recovery
The relative recoveries were estimated by measuring spiked samples of
α‐, β/γ‐ and δ‐tocopherol at two different concentrations with three
replicates of each. No significant differences were observed for the
lower and higher concentrations. The recoveries for the serum samples
ranged from 86 to 105%, from 95 to 108% and from 116 to 124% for
α‐, β/γ‐ and δ‐tocopherol, respectively.
T1
T2
T3
F3
F4
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802.6 | Statistics
All statistical calculations were performed with the use of the freely
available R software (R Development Core Team, 2002) according to
the International Federation of Clinical Chemistry and LaboratoryMed-
icine and Clinical and Laboratory Standards Institute guidelines
(Horowitz, 2016). Based on these guidelines, the minimum required
number of individuals for the determination of RI with the bootstrap
method is at least 100. First we checked the distribution of our data
with the Anderson–Darling test and we also performed the Levene test
for analysis of the homogeneity of variances. If the distribution proved
to be Gaussian and the variances were equal, one‐way ANOVA was
applied to compare the groups, otherwise the Kruskal–Wallis test was
utilized. To obtain the necessary quantiles and their confidence inter-
vals for the determination of the reference intervals, the bootstrap
method (1000 iterations) was applied. The correlation between the con-
centration of themeasured compounds and the age of individuals in the
sample population was examined with the nonparametric Spearman's
test.We rejected the null hypothesis when the corrected p‐values were
≤0.05, and in such cases the differences were considered significant.
Data with Gaussian or non‐Gaussian distributions were plotted as
means (SD) or medians (and interquartile range), respectively.
81
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873 | RESULTS
The group‐wise comparisons failed to detect any significant difference
between groups regarding the concentrations of α‐tocopherol
(p = 0.48, χ2 = 2.46; Kruskal–Wallis test), β/γ‐tocopherol (p = 0.47,TABLE 1 Serum tocopherol concentrations of subjects belonging to the c
Controls (women) Controls (men) ON
α‐Tocopherol (μM) 38.08 (33.70–44.10) 35.38 (31.35–45.83) 3
β/γ‐Tocopherol (μM) 1.83 (1.32–2.23) 1.68 (1.39–2.52)
δ‐Tocopherol (μM) 0.63 (0.52–0.86) 0.62 (0.53–0.78)
Group‐wise comparisons (Kruskal–Wallis test) of the four groups failed to detec
sented as median and interquartile range. OND, Other neurological disease.
TABLE 2 The calculated uncorrected lower (2.5%) and upper (97.5%) refe
(n = 120)
2.5% SE CI
α‐Tocopherol (μM) 24.62 0.76 23.24
β/γ‐Tocopherol (μM) 0.81 0.13 0.60
δ‐Tocopherol (μM) 0.29 0.03 0.22
SE, Standard error; CI, confidence interval.
TABLE 3 The calculated cholesterol corrected lower (2.5%) and upper (97
population (n = 120)
2.5% SE
α‐Tocopherol (μmol/mmol) 5.11 0.14
β/γ‐Tocopherol (μmol/mmol) 0.14 0.02
δ‐Tocopherol (μmol/mmol) 0.06 0.01χ2 = 2.53; Kruskal–Wallis test) or δ‐tocopherol (p = 0.82, χ2 = 0.94;
Kruskal–Wallis test; Table 1).
Accordingly, in order to establish RI with appropriate subject
numbers, the values for each measured compounds were pooled
and the minimum required sample size (n = 120) was achieved. For
the determination of lower (2.5%) and upper (97.5%) RI with the
corresponding confidence intervals and standard errors, the boot-
strap method was applied and the results are demonstrated in
Table 2.
To obtain cholesterol‐corrected tocopherol values as well,
serum cholesterol concentrations were determined for each subject
[median and interquartile range 4.99mM (4.31–5.54)] and the
tocopherol/cholesterol ratios were calculated. The bootstrap
method was applied again for the lipid corrected values (Table 3).
To assess the incidental effect of age on measured serum lipid
levels, the Spearman test was performed. The cholesterol levels
positively correlated with the age of subjects (p < 0.001, Spearman's
ρ = 0.34; Figure 3).
In the case of uncorrected α‐ and β/γ‐tocopherol concentra-
tions, this correlation with age is present as well (α‐tocopherol:
p = 0.002, Spearman's ρ = 0.28, Figure 4A; β/γ‐tocopherol:
p = 0.001, Spearman's ρ = 0.29, Figure 4C) whereas δ‐tocoph-
erol levels did not correlate with age (p = 0.98, Spearman's
ρ = 0.003, Figure 4E). When tocopherol levels were normalized to
cholesterol levels, all the correlations with age were eliminated
(α‐tocopherol: p = 0.99, Spearman's ρ = −0.0007, Figure 4B; β/γ‐
tocopherol: p = 0.14, Spearman's ρ = 0.14, Figure 4D; δ‐tocopherol:
p = 0.051, Spearman's ρ = − 0.18, Figure 4F).ontrol and OND groups
D patients (women) OND patients (men) Group comparisons (p)
4.26 (29.40–41.60) 33.93 (30.54–41.08) 0.48 (χ2 = 2.46)
1.57 (1.33–1.82) 1.75 (1.52–2.21) 0.47 (χ2 = 2.53)
0.62 (0.55–0.82) 0.65 (0.57–0.75) 0.82 (χ2 = 0.94)
t any significant difference between serum tocopherol levels. Data are pre-
rence intervals for tocopherols for the assessed Hungarian population
(95%) 97.5% SE CI (95%)
–26.26 54.67 4.09 46.88–61.84
–1.11 3.69 0.45 2.71–4.55
–0.32 1.07 0.13 0.80–1.29
.5%) reference intervals for tocopherols for the assessed Hungarian
CI (95%) 97.5% SE CI (95%)
4.79–5.36 11.27 0.69 9.91–12.82
0.10–0.19 0.72 0.07 0.60–0.88
0.05–0.07 0.22 0.03 0.16–0.27
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FIGURE 4 Serum tocopherol concentrations and tocopherol/cholesterol r
positively correlates with age (p = 0.002, Spearman's ρ = 0.28; A), similarly t
tocopherol levels do not correlate with age (p = 0.98, Spearman's ρ = 0.003
Spearman's ρ = −0.0007; B) and β/γ‐tocopherol (p = 0.14, Spearman's ρ = 0.1
of δ‐tocopherol levels with age also remained nonsignificant (p = 0.051, Sp
FIGURE 3 Serum cholesterol concentrations in function of age. There
is a positive correlation between cholesterol levels and age (p < 0.001,
Spearman's ρ = 0.34)
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764 | DISCUSSION
The determination of exact serum tocopherol concentrations may be
substantial for the diagnosis and therapeutic monitoring of certain con-
ditions usually accompanied by neurological symptoms, such as ataxia,
myopathy or cognitive deficiency (La Fata, Weber, & Mohajeri, 2014;
Muller, 2010). Although the symptoms of genetically determined disor-
ders with tocopherol deficiency usually manifest during childhood
(Raizman et al., 2014), malabsorption disorders and late‐onset geneti-
cally determined metabolic conditions preferentially appear in adult-
hood, indicating the need for tocopherol measurement in adult
population as well (Ueda et al., 2009). However, these concentrations
alone hold little diagnostic value, for proper evaluation physicians need
a well‐established RI, which can considerably vary between popula-
tions (Table S1 in the Supporting Information). The underlying cause
of this variation may be multifactorial, mainly including nonstandard-
ized patient selection criteria and some methodological issues. Theatios plotted against the age of participants. The level of α‐tocopherol
o β/γ‐tocopherol (p = 0.001, Spearman's ρ = 0.29; C), whereas δ‐
; E). The cholesterol corrected values of α‐tocopherol (p = 0.99,
4; D) do not further significantly correlate with age, and the correlation
earman's ρ = −0.18; F)
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114aim of the current study was to establish RIs for the Hungarian popu-
lation and to compare the method of patient selection and the analyt-
ical procedure with those of previously published studies.
The investigated population in this study is homogeneously dis-
tributed with regard to age and covers a considerably wide age range
for the adult population. The selection of a homogeneous study popu-
lation may have a special importance, because age distribution can
considerably influence reference values in light of the fact that the
levels of certain tocopherols significantly increase with age (Figure 4;
Rifkind & Segal, 1983). Accordingly when the investigated reference
population includes young individuals, the results may be skewed to
lower levels (Ford, Schleicher, Mokdad, Ajani, & Liu, 2006; Paliakov
et al., 2009; Quesada, Mata‐Granados, & Luque De Castro, 2004;
Zhao, Monahan, McNulty, Gibney, & Gibney, 2014). Moving on to
another qualitative aspect of the composition of the study population,
in addition to the involvement of subjects without any chronic illness,
the group of assessed individuals also comprised patients with differ-
ent neurological disorders where tocopherol levels were not previously
reported to be abnormal (the establishment of the so‐called control
group of OND). This study setup may ensure the absence of significant
alterations of tocopherol levels in neurological cases lacking the symp-
toms of ataxia, myopathy and cognitive deficiency, which may be
important for future screening studies. Following thorough statistical
assessment resulting in the lack of significant differences, these sub-
groups become suitable for pooling, i.e. the number of individuals in
the reference population can be increased easily to the desired level.
Several previous studies lack this study setup including well‐detailed
description of the health condition of reference individuals, possibly
introducing a bias into the reference values (Table S1; Paliakov et al.,
2009; Quesada et al., 2004). In the current study design, special atten-
tion was paid to dietary factors and to the intake of special medicines
(e.g. statins) and food supplements as well, because these may consid-
erably alter the levels of the assessed compounds (Colquhoun et al.,
2005). The lack of this kind of standardization introduces another bias
into the establishment of RIs (Table S1; Winbauer, Pingree, & Nuttall,
1999; Yuan et al., 2014).
With regard to the analytical procedure of the determination of
tocopherol concentrations from biological matrices, several difficul-
ties can emerge as well. While the use of serum or heparinized
plasma for measurement does not affect α‐tocopherol level (Table
S1), the application of oxalate, citrate or ethylenediaminetetraacetic
acid significantly reduces its concentration (Nierenberg & Lester,
1985). The most problematic step in the measurement process may
be the sample preparation, which includes liquid–liquid extraction
into n‐hexane, evaporation under nitrogen flow and reconstitution
in organic solvents. The emerging problems during these steps and
during sample injection can considerably contribute to the overall
error of the measurement. Internal standards in known quantity
can be utilized to compensate for the bias between the measured
and true concentrations. In the current study, rac‐tocol was applied
as internal standard, but several other compounds can be utilized
(Table S1).
Another important matter may be the validation of the applied
analytical procedure, which can provide valuable information about
the robustness of the measurement and the validity of the reportedvalues. For scientific publications at least a partial method validation
is required (ICH, 1995). Without method validation the reliability of
the presented data is questionable. Approximately 80% of the previous
studies presenting human tocopherol concentrations applied a valida-
tion procedure (Table S1).
Tocopherol levels are often reported as tocopherol–cholesterol
ratios based on the fact that there is a close relationship between
the concentrations of tocopherols and lipids in the blood (Thurnham,
Davies, Crump, Situnayake, & Davis, 1986). However, under special
circumstances lipid‐corrected tocopherol levels can be misleading,
because it was reported that malnutrition and infectious diseases in
children can lower the levels of circulating cholesterol and its lipopro-
tein carriers, which alteration can mask decreased tocopherol levels if
only corrected values are reported (Das, Thurnham, & Das, 1996;
Sauerwein et al., 1997; Squali Houssaïni et al., 2001). Contrarily, when
obese children were investigated, their α‐tocopherol levels were nor-
mal while their tocopherol–cholesterol ratios were significantly lower
compared with the control group (Strauss, 1999). With regard to
adults, in light of the fact that lipid status can vary with aging
(Figure 3; Rifkind & Segal, 1983), the application of lipid‐corrected
values may be necessary for the characterization of vitamin E status
(Horwitt, Harvey, Dahm, & Searcy, 1972; Thurnham et al., 1986).
Nevertheless, the report of serum tocopherol concentrations with lipid
ratios may be practical for the proper evaluation of tocopherol status.
However, only one‐third of the papers reported both of them
(Table S1 in the Supporting Information).
In conclusion, the current study presents RIs for the first time for
serum tocopherol concentrations and their corresponding cholesterol
corrected values with regard to the adult Hungarian population. These
results can facilitate the diagnostic process for certain neurological
conditions, such as ataxia with vitamin E deficiency. Moreover, this
paper draws attention to the importance of thorough design associ-
ated with the establishment of these RIs and the possible pitfalls in
tocopherol measurements.ACKNOWLEDGEMENTS
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